Drug Metabolism in Peroxisomes: Involvement of Peroxisomal β-Oxidation System in the Oxidative Chain-shortening of Xenobiotic Acyl Compounds

Drug Metabolism And Pharmacokinetics

Volumn 18, Issue 3, 2003, Pages 155-162

  Suga, Tetsuya ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

drug metabolism; mitochondria; peroxisome; peroxisome disorder; xenobiotic acyl compound; Zellweger syndrome; oxidation

Indexed keywords

EID: 85009625560     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.18.155     Document Type: Review

References (13)

1. Kubo, K., Watanabe, T. and Suga, T.: Metabolism of eicosapentaenoic acid in the liver of rats: Participation of the peroxisomal β-oxidation system in chain-shortening. Chem. Pharm. Bull., 36, 305-311 (1988).
2. Suzuki, H., Yamada, J., Watanabe, T. and Suga, T.: Compartmentation of dicarboxylic acid β-oxidation in rat liver: Importance of peroxisomes in the metabolism of dicarboxylic acids. Biochim. Biophys. Acta, 990, 25-33 (1989).
3. Yamada, J., Ogawa, S., Horie, S., Watanabe, T. and Suga, T.: Participation of peroxisomes in the metabolism of xenobiotic acyl compounds: Comparison between peroxisomal and mitochondrial β-oxidation of ?-phenyl fatty acids in rat liver. Biochim. Biophys. Acta, 921, 292-301 (1987).
4. Yamada, J., Itoh, S., Horie, S., Watanabe, T. and Suga, T.: Chain-shortening of a xenobiotic acyl compound by the peroxisomal β-oxidation system in rat liver. Biochem. Pharmacol., 35, 4363-4368 (1986).
5. Suzuki, H., Mori, K., Yamada, J. and Suga, T.: Contribution of peroxisomal β-oxidation system to the chain-shortening of N-(a-methylbenzyl)azelaamic acid in rat liver. Biochem. Pharmacol., 39, 1975-1981 (1990).
6. Yamada, J., Horie, S., Watanabe, T. and Suga, T.: Participation of peroxisomal β-oxidation system in the chain-shortening of a xenobiotic acyl compound. Biochem. Biophys. Res. Commun., 125, 123-128 (1984).
7. Knoop, F.: β-Oxidation of phenylfatty acids in the dog. Beitr. Chem. Physiol. Pathol., 6, 150-162 (1905).
8. Lazarow, P. B. and de Duve, C.: Fatty acid β-oxidation system in peroxisomes. Proc. Natl. Acad. Sci. USA, 73, 2043-2046 (1976).
9. De Duve, C., Pressman, R., Gianetto, R., Wattiaux, R. and Appelmans, F.: A new method of subcellular fractionation, differential centrifugation method. Biochem. J., 60, 604-615 (1955).
10. Wanders, R. J. A., Schutgens, R. B. H., Heymans, H. S. A., Collins, I., Goldfischer, S., Hashimoto, T. and Schram, A. W.: Biochemical analysis in peroxisomal disorders. In Peroxisomes in Biology and Medicine ed by Fahimi, H. D. and Sies, H., pp 341-440 (1986).
11. Schutgens, R. B. H., Heymans, H. S. A., Wanders, R. J. A., van den Bosch, H. and Tager, J. M.: Peroxisomal disorders: A newly recognized group of genetic diseases. Eur. J. Pediatr., 144, 430-440 (1986).
12. Suzuki, H., Yamada, J., Watanabe, T. and Suga, T.: A specific method for determination of peroxisomal β-oxidation activity in cultured human fibroblasts using a specific substrate, C9: A possible application for screening of peroxisomal disorders. Clin. Chim. Acta, 207, 19-29 (1992).
13. Yoshida, Y., Yamada, J., Watanabe, T., Suga, T. and Takayama, H.: Participation of the peroxisomal β-oxidation system in the chain-shortening of PCA16, a metabolite of the cytosine arabinoside prodrug, YNK-01, in rat liver. Biochem. Pharmacol., 39, 1505-1512 (1990).